Matches in Wikidata for { <http://www.wikidata.org/entity/Q38115382> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- Q38115382 description "article científic" @default.
- Q38115382 description "article scientifique" @default.
- Q38115382 description "articol științific" @default.
- Q38115382 description "articolo scientifico" @default.
- Q38115382 description "artigo científico" @default.
- Q38115382 description "artigo científico" @default.
- Q38115382 description "artigo científico" @default.
- Q38115382 description "artikel ilmiah" @default.
- Q38115382 description "artikull shkencor" @default.
- Q38115382 description "artículo científico" @default.
- Q38115382 description "artículu científicu espublizáu en 2013" @default.
- Q38115382 description "bilimsel makale" @default.
- Q38115382 description "scienca artikolo" @default.
- Q38115382 description "scientific article published on 15 June 2013" @default.
- Q38115382 description "scientific article published on 15 June 2013" @default.
- Q38115382 description "scientific article published on 15 June 2013" @default.
- Q38115382 description "vedecký článok" @default.
- Q38115382 description "vetenskaplig artikel" @default.
- Q38115382 description "videnskabelig artikel" @default.
- Q38115382 description "vitenskapelig artikkel" @default.
- Q38115382 description "vitskapeleg artikkel" @default.
- Q38115382 description "vědecký článek" @default.
- Q38115382 description "wetenschappelijk artikel" @default.
- Q38115382 description "wissenschaftlicher Artikel" @default.
- Q38115382 description "наукова стаття, опублікована в червні 2013" @default.
- Q38115382 description "научная статья" @default.
- Q38115382 description "научни чланак" @default.
- Q38115382 description "מאמר מדעי" @default.
- Q38115382 description "مقالة علمية نشرت في 15 يونيو 2013" @default.
- Q38115382 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38115382 name "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 name "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 name "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 type Item @default.
- Q38115382 label "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 label "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 label "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 prefLabel "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 prefLabel "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 prefLabel "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 P1433 Q38115382-15CB0149-27CA-4BF1-8154-3BDA6E907608 @default.
- Q38115382 P1476 Q38115382-25D13F2B-31CA-452D-9AFB-AA371C6362EF @default.
- Q38115382 P2093 Q38115382-F8AFCA5E-9B39-49E3-B67A-1AE9228C18B4 @default.
- Q38115382 P304 Q38115382-3B5AE07D-1A77-4CF1-A008-B86E5826CC12 @default.
- Q38115382 P31 Q38115382-BDDB536D-228A-47C7-8E48-7A6CDEE325B2 @default.
- Q38115382 P356 Q38115382-346BFD94-9AA0-4E48-B9E9-D5296AA3EC80 @default.
- Q38115382 P433 Q38115382-AE6FE63F-9D35-493B-AD86-6DC79E6A5B03 @default.
- Q38115382 P478 Q38115382-15543EC1-B58A-429C-84BD-AEF9A9857357 @default.
- Q38115382 P50 Q38115382-143B2FEF-573F-4365-B6A6-10E557D5BA6B @default.
- Q38115382 P50 Q38115382-3C7A0804-D5FF-4D81-9B36-17BDFFC668FE @default.
- Q38115382 P50 Q38115382-4A987414-D5CA-48A0-913B-4BE445040419 @default.
- Q38115382 P50 Q38115382-5816A90F-3E5A-4949-9574-A88331E58A43 @default.
- Q38115382 P50 Q38115382-58E487C3-CCC0-47E3-A37B-CFCFD3C2E780 @default.
- Q38115382 P50 Q38115382-665354DE-F65E-447E-B514-B4FC36C5085C @default.
- Q38115382 P50 Q38115382-AB53849D-F1BF-4DBC-AD5D-FEEC53C51AC0 @default.
- Q38115382 P50 Q38115382-BEBB7594-E469-4ADD-9195-F52FAC2356F0 @default.
- Q38115382 P577 Q38115382-7FCA4D6E-7E91-45AC-8AA6-A79F0F0FF3E1 @default.
- Q38115382 P5875 Q38115382-299EE123-B0C8-4295-9F2F-B02A8D0F75D1 @default.
- Q38115382 P698 Q38115382-D7CB35F1-45A6-446F-8E6A-95656D42312F @default.
- Q38115382 P8608 Q38115382-5BACBC4E-887E-4A96-9C7F-E4FFBC05E0F5 @default.
- Q38115382 P921 Q38115382-0393B4BE-C5F7-45C7-A8D9-0C7AB4D79BF1 @default.
- Q38115382 P921 Q38115382-BF16BA7C-2AF1-4C87-B7FF-84EF40401868 @default.
- Q38115382 P356 J.AUTREV.2013.05.004 @default.
- Q38115382 P698 23777822 @default.
- Q38115382 P1433 Q15754966 @default.
- Q38115382 P1476 "Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab" @default.
- Q38115382 P2093 "Nathalie Morel" @default.
- Q38115382 P304 "1085-1090" @default.
- Q38115382 P31 Q13442814 @default.
- Q38115382 P356 "10.1016/J.AUTREV.2013.05.004" @default.
- Q38115382 P433 "11" @default.
- Q38115382 P478 "12" @default.
- Q38115382 P50 Q114416227 @default.
- Q38115382 P50 Q114416229 @default.
- Q38115382 P50 Q1515807 @default.
- Q38115382 P50 Q47262464 @default.
- Q38115382 P50 Q51289694 @default.
- Q38115382 P50 Q53547424 @default.
- Q38115382 P50 Q60326205 @default.
- Q38115382 P50 Q90968221 @default.
- Q38115382 P577 "2013-06-15T00:00:00Z" @default.
- Q38115382 P5875 "262043858" @default.
- Q38115382 P698 "23777822" @default.
- Q38115382 P8608 "release_vixoujwkq5bixktibzg2ttqzsm" @default.
- Q38115382 P921 Q412323 @default.
- Q38115382 P921 Q5051580 @default.